Investmark Advisory Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$245K Sell
8,728
-102,668
-92% -$2.73M 0.1% 120
2025
Q4
$2.77M Buy
111,396
+2,567
+2% +$64.7K 1.18% 28
2025
Q3
$2.77M Buy
108,829
+9,166
+9% +$226K 1.2% 26
2025
Q2
$2.42M Buy
99,663
+4,055
+4% +$94.6K 1.13% 27
2025
Q1
$2.42M Buy
95,608
+12,852
+16% +$336K 1.2% 24
2024
Q4
$2.2M Sell
82,756
-8,351
-9% -$227K 1.08% 28
2024
Q3
$2.64M Buy
91,107
+1,723
+2% +$50.3K 1.28% 25
2024
Q2
$2.5M Buy
89,384
+1,587
+2% +$43.7K 1.33% 25
2024
Q1
$2.44M Buy
87,797
+37,075
+73% +$1.03M 1.34% 24
2023
Q4
$1.46M Sell
50,722
-29,350
-37% -$887K 0.86% 31
2023
Q3
$2.66M Buy
80,072
+804
+1% +$28.4K 1.8% 15
2023
Q2
$2.91M Buy
79,268
+892
+1% +$34.7K 1.94% 15
2023
Q1
$3.2M Buy
78,376
+4,829
+7% +$209K 2.35% 14
2022
Q4
$3.77M Buy
73,547
+5,279
+8% +$253K 2.79% 8
2022
Q3
$2.99M Buy
68,268
+2,202
+3% +$107K 2.68% 11
2022
Q2
$3.46M Buy
66,066
+1,363
+2% +$69.5K 3.42% 7
2022
Q1
$3.35M Buy
64,703
+1,567
+2% +$81.3K 3.45% 8
2021
Q4
$3.73M Buy
+63,136
New +$3.13M 3.49% 6

Other funds holding PFE

Investmark Advisory Group's PFE Position: Q1 2026 in Review

Investmark Advisory Group reduced its Pfizer (PFE) stake by 92% in Q1 2026, selling an estimated $2.73M and leaving 8,728 shares worth $245K. The position accounts for 0.1% of the portfolio, ranked #120.

Investmark Advisory Group first reported a position in PFE in Q4 2021 and has held it in 18 quarters since. The position peaked at $3.77M in Q4 2022. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Investmark Advisory Group held 8,728 shares of Pfizer worth $245K as of Q1 2026.
  • Investmark Advisory Group sold 102,668 Pfizer shares in Q1 2026, an estimated $2.73M.
  • Pfizer made up 0.1% of Investmark Advisory Group's portfolio in Q1 2026, its #120 holding.
  • Investmark Advisory Group first reported a position in Pfizer in Q4 2021 and has held it in 18 quarters since.
  • Investmark Advisory Group's Pfizer position peaked at $3.77M in Q4 2022.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Investmark Advisory Group's 13F filing for Q1 2026, filed 15 May 2026.